Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Colorado for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Colorado only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Colorado (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Robert Courtney (NPI 1760649024)

Field	Value
Entity Type	Individual
Organization	Robert Courtney
Address	1050 W South Boulder Rd Ste 2100
City	Lafayette
State	CO
ZIP	80026
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	May 22, 2008

Payer Source	Total Paid
Medicare	$2.9M
Medicaid	$0

Key Findings

Practice appears to be a procedure-first retina specialty focused on intravitreal drug administration and posterior-segment diagnostics: J0178 is by far the largest line item with 2.8K claims, $692 avg paid/claim, $2M revenue (67.8% of Medicare revenue), supported by high volumes of 67028 (2.2K claims, $94 avg paid/claim, $209.1K revenue, 7.3%) and 92134 (2.7K claims, $30 avg paid/claim, $81.6K revenue, 2.8%). The mix of high-volume injection codes and retinal imaging/procedure codes indicates most clinical activity and reimbursement derive from in-office procedures rather than non-procedural care.

Revenue is highly concentrated in a very small set of Medicare codes: the precomputed top 3 codes account for 83.0% of this provider's total Medicare revenue, with J0178 contributing the majority share. That concentration signals dependence on a handful of drug and procedure reimbursements — a meaningful commercial exposure if utilization or reimbursement for those specific codes changed.

This provider is effectively a Medicare-only biller in the dataset: total Medicare revenue is $2.9M while there is no Medicaid billing on file. The absence of Medicaid activity means the provider has limited or no reported exposure to state-managed care reimbursement and is functionally a single-payer (Medicare) practice in this dataset, which concentrates payer risk.

Competitive standing on key codes shows the provider is a high-volume national participant in intravitreal therapy and retinal imaging. J0178 ranks #214 of 3204 providers (93th percentile; notably above typical national volume) and 92134 ranks #537 of 26868 providers (98th percentile; extreme outlier), indicating above-average or extreme national volume for those services compared with peers.

Not all service lines are unusually large: several additional retinal drug and surgical codes are within typical national ranges. For example, J2777 (7.8K claims, $29 avg paid/claim, $226.2K revenue, 7.9%) is described as typical/unremarkable and ranks #1194 of 2039 (41th percentile), while J2778 (647 claims, $182 avg paid/claim, $117.8K revenue, 4.1%) and J2781 (525 claims, $120 avg paid/claim, $63K revenue, 2.2%) are also positioned around median peer volumes, reflecting a mix of both dominant and typical lines.

Operational profile shows limited reliance on office E/M revenue relative to procedure revenue: 92014 (857 claims, $89 avg paid/claim, $76.3K revenue, 2.7%) and 99204 (133 claims, $125 avg paid/claim, $16.6K revenue, 0.6%) together make up a small share of Medicare revenue compared with procedural/drug codes. This pattern is consistent with a practice model structured around recurring in-office procedures and injected therapeutics rather than high-volume medical evaluations.

Drug utilization is dominated by a single biologic with secondary use of newer or alternative agents: J0178 (aflibercept) accounts for $2M revenue and 2.8K claims, while other intravitreal drugs such as J2777 (faricimab), J2778 (ranibizumab), and J2781 (pegcetacoplan) contribute smaller, more typical volumes. That profile suggests formularies or clinical preference strongly favor aflibercept in this practice while still incorporating other retinal biologics at customary levels.

Tenure data show a long-established billing presence: the NPI was enumerated 2008-05-22 (~18 years ago), indicating sustained participation in Medicare and an established referral footprint over nearly two decades. Combined with the high-volume procedure codes, the tenure supports the interpretation of a mature, procedure-focused retina practice rather than a newly established operation.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

18 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	2,820	$690	$2M
J2777	Injection, faricimab‑svoa, 0.1 mg	7,800	$30	$226.2K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	2,220	$90	$209.1K
J2778	Injection, ranibizumab, 0.1 mg	650	$180	$117.8K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,720	$30	$81.6K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	860	$90	$76.3K
J2781	Injection, pegcetacoplan, intravitreal, 1 mg	530	$120	$63K
J3590	Unclassified biologics	20	$2,120	$46.6K
67042	In this procedure, the provider removes vitreous humor, the gelatinous material that gives shape to the eye, using a mechanical cutting tool. He removes the internal limiting membrane of the retina…	20	$930	$21.3K
J7999	Compounded drug, not otherwise classified	280	$70	$20.9K

Showing 1–10 of 18

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 18 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Colorado Distribution

Robert Courtney — 5 of 18 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Colorado

Full comparison — all codes billed, vs. state median

18 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	2	60	740	$690	$618.3K
J2777	23	40	8,910	$30	$456.1K
J2778	10	20	600	$180	$199.7K
J3590	3	10	20	$2,200	$94.6K
J2781	7	10	470	$120	$79.4K
67028	2	80	670	$100	$73.3K
67036	15	30	20	$1,100	$37.3K
67042	12	30	20	$1,140	$29.6K
67108	20	20	20	$1,260	$26.5K
J7999	16	50	230	$70	$21.5K

Showing 1–10 of 18

Related Providers

Other providers that share a Tax Identification Number (TIN) with Robert Courtney, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Salil Shukla	CO	Retina Specialist (Ophthalmology) Physician	$2.7M	$0
Murtaza Adam	CO	Retina Specialist (Ophthalmology) Physician	$2.3M	$0
Mimi Liu	CO	Retina Specialist (Ophthalmology) Physician	$2.2M	$0
Miriah Teeter	CO	Retina Specialist (Ophthalmology) Physician	$1.9M	$0
Nancy Christmas	CO	Retina Specialist (Ophthalmology) Physician	$1.8M	$0
Peter Hovland	CO	Ophthalmology Physician	$1.8M	$0
Curtis Hagedorn	CO	Ophthalmology Physician	$1.5M	$0
David Johnson	CO	Specialist	$1.5M	$0
Ashleigh Levison	CO	Retina Specialist (Ophthalmology) Physician	$1.4M	$0
Brian Joondeph	CO	Retina Specialist (Ophthalmology) Physician	$1.4M	$0

Nearby Providers

Other providers in the same ZIP code as Robert Courtney, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Developmental Disabilities Center	CO	Developmentally Disabled Services Day Training Agency	$0	$114.2M
Karuna Care Services	CO	Developmentally Disabled Services Day Training Agency	$0	$28.4M
Clinica Campesina Family Health Services	CO	Federally Qualified Health Center (FQHC)	$0	$16.2M
Tru Community Care	CO	PACE Provider Organization	$0	$11.2M
Developmental Disabilities Center	CO	Case Management Agency	$0	$11.1M
Clinica Campesina Family Health Services	CO	Clinic/Center	$0	$7.1M
Behavior Services Of The Rockies	CO	Community/Behavioral Health Agency	$0	$5.6M
Summit Supports LLC	CO	Intellectual and/or Developmental Disabilities Community Based Residential Treatment Facility	$0	$4.5M
Behavior Services Of The Rockies	CO	Community/Behavioral Health Agency	$0	$3.9M
Community Roots, LLC	CO	Intellectual and/or Developmental Disabilities Community Based Residential Treatment Facility	$0	$3.5M

Robert Courtney — Billing Profile & Reimbursement Data

Sign up for Robert Courtney — Billing Profile & Reimbursement Data policy alerts

Robert Courtney — Billing Profile & Reimbursement Data

Sign up for Robert Courtney — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References